These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1582825)

  • 1. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents.
    Lasser EC
    Invest Radiol; 1992 May; 27(5):397-9. PubMed ID: 1582825
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-osmolality versus high-osmolality contrast material.
    Korn WT; Bettmann MA
    Curr Opin Radiol; 1992 Apr; 4(2):9-15. PubMed ID: 1554592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intravascular low-osmolality contrast agents.
    Swanson DP; Thrall JH; Shetty PC
    Clin Pharm; 1986 Nov; 5(11):877-91. PubMed ID: 3780159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-osmolality and low-osmolality contrast agents.
    Paulin S
    N Engl J Med; 1992 Jul; 327(3):202-3; author reply 204-5. PubMed ID: 1608418
    [No Abstract]   [Full Text] [Related]  

  • 5. Nephrotoxicity of low osmolality contrast media versus high osmolality media.
    Steinberg EP; Moore RD; Brinker JA; Fishman EK; Powe NR; Graziano SL; Gopalan R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S86; discussion S88-91. PubMed ID: 1808157
    [No Abstract]   [Full Text] [Related]  

  • 6. Safer contrast agents?
    Dawson P; Allison DJ
    Br J Hosp Med; 1989 Nov; 42(5):406-7. PubMed ID: 2597825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal tolerance of iodinated low osmolality contrast agents. Clinical and experimental aspects].
    Deray G; Dubois M; Bellin MF; Grellet J; Jacobs C
    J Radiol; 1990; 71(6-7):439-44. PubMed ID: 2254874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision analysis to assess cost-effectiveness of low-osmolality contrast medium for intravenous urography.
    Calvo MV; Pilar del Val M; Mar Alvarez M; Domínguez-Gil A
    Am J Hosp Pharm; 1992 Mar; 49(3):577-84. PubMed ID: 1598930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis.
    Caro JJ; Trindade E; McGregor M
    AJR Am J Roentgenol; 1991 Apr; 156(4):825-32. PubMed ID: 1825900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
    Rudnick MR; Goldfarb S
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents. Report of a multidisciplinary working group.
    Lawrence V; Matthai W; Hartmaier S
    Invest Radiol; 1992 Jan; 27(1):2-28. PubMed ID: 1733876
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal adverse event secondary to high osmolality contrast agent.
    Guharoy R; Medicis J; Lehmann D
    Vet Hum Toxicol; 1998 Oct; 40(5):285-7. PubMed ID: 9778765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodinated radiographic contrast media: comparison of low-osmolar with conventional ionic agents [corrected].
    Rubin JD; Cohan RH
    Curr Opin Radiol; 1991 Oct; 3(5):637-45. PubMed ID: 1931499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective use of radiographic low-osmolality contrast media in the 1990s.
    Ellis JH; Cohan RH; Sonnad SS; Cohan NS
    Radiology; 1996 Aug; 200(2):297-311. PubMed ID: 8685315
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced side effects of low osmolality non-ionic contrast media in coronary arteriography. Comparative experimental study in dogs.
    Schräder R; Baller D; Hoeft A; Korb H; Wolpers HG; Hellige G
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():67-77. PubMed ID: 6139083
    [No Abstract]   [Full Text] [Related]  

  • 16. High-osmolality and low-osmolality contrast agents.
    Gertz EW
    N Engl J Med; 1992 Jul; 327(3):203; author reply 204-5. PubMed ID: 1608419
    [No Abstract]   [Full Text] [Related]  

  • 17. Malpractice, informed consent, and the use of low osmolality contrast media.
    Eisner JM; Casey BJ
    Conn Med; 1988 Feb; 52(2):87-91. PubMed ID: 3278846
    [No Abstract]   [Full Text] [Related]  

  • 18. High-osmolality and low-osmolality contrast agents.
    Parfrey PS; Barrett BJ
    N Engl J Med; 1992 Jul; 327(3):204-5. PubMed ID: 1608421
    [No Abstract]   [Full Text] [Related]  

  • 19. [Low osmolality contrast media in excretory urography].
    Suzuki S; Yamazaki E
    Rinsho Hoshasen; 1987 Feb; 32(2):253-62. PubMed ID: 3295330
    [No Abstract]   [Full Text] [Related]  

  • 20. High-osmolality and low-osmolality contrast agents.
    Rudoff J; Phillips L
    N Engl J Med; 1992 Jul; 327(3):203-4. PubMed ID: 1608420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.